实用肝脏病杂志 ›› 2023, Vol. 26 ›› Issue (1): 132-135.doi: 10.3969/j.issn.1672-5069.2023.01.034

• 胆石症 • 上一篇    下一篇

LC联合ERCP治疗胆囊结石合并肝外胆管结石患者疗效研究*

刘颂航, 高友逵, 曹良启   

  1. 510260 广东省广州市海珠区广州医科大学附属第二医院肝胆外科
  • 收稿日期:2022-05-24 出版日期:2023-01-10 发布日期:2023-02-07
  • 通讯作者: 曹良启,E-mail:clq0829@163.com
  • 作者简介:刘颂航,男,36岁,医学硕士,主治医师。E-mail:jameslau2010@163.com
  • 基金资助:
    *广州市科技计划项目(编号:202102010090)

Clinical efficacy of LC and ERCP in the treatment of patients with gallbladder and extrahepatic bile duct stones

Liu Songhang, Gao Youkui, Cao Liangqi   

  1. Department of Hepatobiliary Surgery, Second Affiliated Hospital, Guangzhou Medical University, Zhuhai 510260,Guangzhou Province, China
  • Received:2022-05-24 Online:2023-01-10 Published:2023-02-07

摘要: 目的 探讨采用腹腔镜胆囊切除术(LC)联合内镜下逆行胰胆管造影术(ERCP)治疗胆囊结石合并肝外胆管结石患者的疗效。方法 2018年3月~2022年3月我科收治的142例胆囊结石合并肝外胆管结石患者,其中71例对照组患者接受传统的开腹手术,在另71例观察组患者行LC联合ERCP术治疗。采用免疫比浊法检测血清C反应蛋白(CRP)水平,采用固相免疫色谱法检测血清降钙素原(PCT)水平,采用双抗体一步夹心法检测血清白介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)水平。结果 观察组手术时间、术中出血量、疼痛评分和住院日和分别为(92.3±8.7)min、(47.9±5.2)mL、(3.8±0.4)分和(5.2±2.3)d,显著少于或短于对照组【分别为(116.4±10.2)min、(76.5±6.4)mL、(4.1±0.5)分和(7.1±2.6)d,P<0.05】,而医疗花费为(3.4±0.4)万元,显著高于对照组【(2.7±0.3)万元,P<0.05】;在术后3 d,观察组血清CRP、IL-6和TNF-α水平分别为(48.4±2.9)mg/L、(9.7±1.2)ng/L和(1.3±0.2)ng/L,显著低于对照组【分别为(61.7±3.1)mg/L、(14.3±1.6)ng/L和(2.4±0.2)ng/L,P<0.05】;术后,观察组并发症,如急性胰腺炎、出血、感染和胆漏发生率为11.3%,显著低于对照组的23.9%(P<0.05)。结论 采用LC联合ERCP治疗胆囊结石合并肝外胆管结石患者可有效改善手术相关指标,保证结石清除率,促进术后恢复。

关键词: 胆囊结石, 肝外胆管结石, 腹腔镜胆囊切除术, 内镜下逆行胰胆管造影术, 治疗

Abstract: Objective The aim of this study was to summarize the clinical efficacy of laparoscopic cholecystectomy (LC) and endoscopic retrograde cholangiopancreatography (ERCP) in the treatment of patients with gallbladder and extrahepatic bile duct stones. Methods 142 patients with gallbladder and extrahepatic bile duct stones were encountered in our hospital between March 2018 and March 2022, and 71 patients in control group were treated with traditional open laparotomy, and another 71 patients in observation group were treated with ERCP and thereafter LC. Serum C-reactive protein (CRP) level was detected by immunoturbidimetry, and serum procalcitonin (PCT) level was detected by solid-phase immunochromatography. Serum interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) levels were assayed by double-antibody one-step sandwich method. Results The surgical time, intraoperative blood loss, the visual analogue scale score and hospital stay in the observation group were (92.3±8.7)min, (47.9±5.2)mL, (3.8±0.4) and (5.2±2.3)d, significantly shorter or less than [(116.4±10.2)min, (76.5±6.4)mL, (4.1±0.5) and (7.1±2.6) d, respectively, P<0.05], while the medical cost was (34000.0±4000.0) yuan, much higher than [(27000.0±3000.0) yuan,P<0.05] in the control; three days after operation, serum CRP, IL-6 and TNF-α levels in the observation were (48.4±2.9)mg/L, (9.7±1.2)ng/L and (1.3±0.2)ng/L, significantly lower than [(61.7±3.1)mg/L, (14.3±1.6)ng/L and (2.4±0.2)ng/L, respectively, P<0.05] in the control; the incidence of post-operationally complications, such as acute pancreatitis, bleeding, infection and bile leak, in the observation was 11.3%, much lower than 23.9%(P<0.05) in the control group. Conclusion The application of ERCP and thereafter LC combination in the treatment of patients with gallbladder and extrahepatic bile duct stones could effectively improve the surgical-related indicators, ensure the stone clearance and promote the postoperative recovery, which might be related to a relatively low systemic inflammatory reactions.

Key words: Gallbladder stones, Extrahepatic bile duct stones, Laparoscopic cholecystectomy, Endoscopic retrograde cholangiopancreatography, Therapy